The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 30, 2018

Filed:

Oct. 02, 2013
Applicant:

Transgene S.a., Illkirch Graffenstaden, FR;

Inventors:

Claude Sene, Strasbourg, FR;

Mélina Chasle, Strasbourg, FR;

Assignee:

Transgene S.A., Illkirch Grafffenstaden, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 7/00 (2006.01); A61K 39/285 (2006.01); A61K 47/18 (2017.01); A61K 47/32 (2006.01); A61K 9/19 (2006.01); A61K 47/26 (2006.01); A61K 47/02 (2006.01);
U.S. Cl.
CPC ...
A61K 39/285 (2013.01); A61K 9/19 (2013.01); A61K 47/183 (2013.01); A61K 47/26 (2013.01); A61K 47/32 (2013.01); C12N 7/00 (2013.01); A61K 47/02 (2013.01); C12N 2710/24134 (2013.01); Y02A 50/463 (2018.01); Y02A 50/481 (2018.01);
Abstract

The present invention relates to formulation comprising (i) at least one virus-based material, (ii) at least one polymer selected in the group of polyvinylpyrrolidone and derivatives thereof, (iii) at least one sugar, (iv) at least two different amino acids, (v) at least two pharmaceutical acceptable salts, wherein at least one of said salts is a phosphate salt and, optionally (vi) a pharmaceutical acceptable buffer. Such a formulation is particularly suitable for freeze-drying. The present invention also relates to the corresponding dry product, as well as its preparation process. The present invention also relates to a reconstituted material comprising said dry product, which can be administered to a patient in need thereof. Such formulation and reconstituted material are useful as vaccines, preferably for the treatment and/or the prevention of cancers, infectious diseases and/or autoimmune disorders.


Find Patent Forward Citations

Loading…